Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-46416  Staphylococcus aureus, AIS2006032
(Bacteria)
Price: All BEI Resources products are provided
at no cost to registered researchers.
Organism: Staphylococcus aureus
Designations: AIS2006032
Biosafety Level: 2
Availability Status: In Stock
Store at: -60°C or colder
Contributor: J Patel
Comments:
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

Staphylococcus aureus (S. aureus), strain AIS2006032 (also referred to as VRS6, VRSA6) was isolated in 2005 in Michigan, USA, from infected non-healing plantar ulcers of a 48-year-old male who had a history of long term vancomycin therapy.

S. aureus, strain AIS2006032 is a vancomycin-resistant S. aureus (VRSA) strain. S. aureus, strain AIS2006032 was deposited as positive for vanA; negative for vanB, vanC1, vanC2, vanD, vanE, PVL and arginine catabolic mobile element (ACME); pulsed-field type USA100; spa repeats TJMGMK; Ridom spa type t062. Originally, the SCCmec locus was classified as non-typable, but later analysis, based on the arrangement of the mec locus, determined it to be mec cassette type II. However, the other two genes used to type the SCCmec locus, ccrA and ccrB, are lacking. S. aureus, strain AIS2006032 is a USA100 isolate. USA100 isolates have the same MLST profile (ST 5), SCCmec (subtype II) and are usually resistant to erythromycin and spectinomycin as well as being multiresistant to other commonly used therapeutic agents. USA100 is the most prevalent U.S. health care-associated pulsed-field type and is endemic in many U.S. hospitals. The complete genome sequence of S. aureus, strain AIS2006032 is available (GenBank: AHBP00000000).

Each vial contains approximately 0.5 mL of bacterial culture in Brain Heart Infusion broth supplemented with 6 µg/mL vancomycin and 10% glycerol.

Note: If homogeneity is required for your intended use, please purify prior to initiating work.
Citations: Acknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain AIS2006032, NR-46416."
Additional Information: NARSA VRS6
PERMITS
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top


Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.


Back to My Search